Check out your Company Bowl for anonymous work chats.
CLEVELAND, Dec. 6, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the completion of its previously announced underwritten public offering of 47,782,500 shares of common stock at a price to the public of $3.13 per share, for gross proceeds of approximately $149.6 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by ViewRay. All of the shares sold in the offering were sold by ViewRay. The shares sold included the full exercise of the underwriters' option to purchase additional shares.
ViewRay, Inc. (NASDAQ: VRAY) announced today that Penn State Health has entered into a master agreement for the purchase of up to four MRIdian systems, placing an order for its first system today. Penn State Health, which includes the Milton S. Hershey Medical Center and St. Joseph Medical Center, has selected MRIdian to offer personalized, precise radiation therapy in its community centers, delivering world-class care to the patients it serves. September 16, 2019
On September 12, 2019, ViewRay, Inc. (NASDAQ: VRAY) announced today that Stanford Health Care in Stanford, California, will acquire a MRIdian, the world’s leading MR-guided radiation therapy system. Stanford Health Care is internationally renowned for its expertise in cancer treatment and translating important medical breakthroughs into patient care. As a leading academic medical center, Stanford Health Care provides state-of-the-art technologies and treatments to help advance care and improve outcomes for patients. http://glassdoor.com/slink.htm?key=vM0Mu
On September 16, 2019, ViewRay, Inc. (NASDAQ: VRAY) announced today that Penn State Health has entered into a master agreement for the purchase of up to four MRIdian systems, placing an order for its first system today. Penn State Health, which includes the Milton S. Hershey Medical Center and St. Joseph Medical Center, has selected MRIdian to offer personalized, precise radiation therapy in its community centers, delivering world-class care to the patients it serves. http://glassdoor.com/slink.htm?key=vM0MD
